Clinical trials: present and future. - Wikidata - awgldk - TriplyDB

Clinical trials: present and future.

Clinical trials: present and future.

http://www.wikidata.org/entity/Q34315139

about

Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays.Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

P2860

Q30865041-B78C3B59-9EF6-4E1B-8AC5-4CFC17F106B5 Q39264219-7CEEDB28-E897-45F7-A507-C1720842937A

P2860

Clinical trials: present and future.

http://www.wikidata.org/entity/Q34315139

description

2001 nî lūn-bûn

@nan

2001 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մարտին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Clinical trials: present and future.

@ast

Clinical trials: present and future.

@en

Clinical trials: present and future.

@nl

type

label

Clinical trials: present and future.

@ast

Clinical trials: present and future.

@en

Clinical trials: present and future.

@nl

prefLabel

Clinical trials: present and future.

@ast

Clinical trials: present and future.

@en

Clinical trials: present and future.

@nl

P1433

Q34315139-5F627C54-D64C-48B1-8A05-184EEA01BD4F

P1476

Q34315139-FA392DDD-4B1C-4DC8-95E6-0CE5F6C4BAB2

P2093

Q34315139-A0C8372D-EF90-4CF3-B324-16897D19E5E8

P2860

Q34315139-08CBC820-3D19-4900-B4FC-01C26EFA18CE

Q34315139-1AE1E86D-182E-424C-B1BE-F9F320CC2FCD

Q34315139-3CD002F9-F0DD-41A4-8540-2F632F6219BE

Q34315139-4C157A1B-7EBD-45DE-84BC-93ACD10BD555

Q34315139-5BEFF149-9532-4562-9D79-A82ACF631C47

Q34315139-85FD73FE-BA70-4636-BAE2-95B89FF301CC

Q34315139-ABC71166-061E-4300-AE72-638D4AA62B29

Q34315139-AC2D1231-73C9-482C-851A-1945CC7B6A9E

Q34315139-C8881532-C1FC-4950-8538-862CF02D900B

Q34315139-CA4CD5C3-B47D-4EC2-9428-398156D3A3E2

P304

Q34315139-7F90B317-3AD8-4BF6-85EC-DAFDB0E4546F

P31

Q34315139-E923FE37-8983-4E51-8F2D-B0934521A580

P356

Q34315139-E0861E3B-0CEC-4BA8-8378-3BAAB0798961

P478

Q34315139-CD30C527-57FD-48B3-B147-08C8A6FF3110

P577

Q34315139-CB51CEA1-8142-4631-B474-FE7FA855B716

P698

Q34315139-38A3E04C-01A6-4AAB-A9CE-D83764E02B7F

P356

14660820152415672

P1433

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases

P1476

Clinical trials: present and future.

@en

P2093

Mitsumoto H

http://www.w3.org/2001/XMLSchema#string

P2860

Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy

Neurotrophic factors and neuromuscular disease: I. General comments, the neurotrophin family, and neuropoietic cytokines.

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research.

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.

Neurotrophic factors: from molecule to man.

Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro.

The natural history of motoneuron loss in amyotrophic lateral sclerosis.

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.

The natural history of amyotrophic lateral sclerosis.

P304

S10-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14660820152415672

http://www.w3.org/2001/XMLSchema#string

P478

2 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11465917

http://www.w3.org/2001/XMLSchema#string